Patient characteristics
MCD patients (n=12) . | AC, HIV coinfected (n=12) . | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Code . | HIV . | Age . | MCD status . | CD4/mm3 . | HIV VL (cp/mL) . | Associated-KS . | HHV-8 VL (cp/1.5 105 PBMC) . | Code . | Age . | CD4/mm3 . | HIV VL (cp/mL) . | HHV-8 VL (cp/1.5 105 PBMC) . |
MCD MED | + | 39 | A | 260 | ND | - | 365 | AC Prog 210 | 42 | 279 | 70 000 | <10 |
MCD NIV | + | 38 | A | 180 | ND | - | <10 | AC Prog 238 | 48 | 273 | <800 | ND |
MCD IOP | + | 56 | A | 171 | 100 000 | A | ND | AC LTNP 9006 | 38 | 258 | 40 000 | <10 |
MCD RAM | + | ND | A | 92 | ND | A | ND | AC Prog 212 | 41 | 258 | <800 | <10 |
MCD NEG | + | 37 | A | 34 | ND | A | 240 | AC Prog 204 | 40 | 254 | ND | <10 |
MCD LOR | + | ND | A | 260 | ND | A | ND | AC Prog REV | 57 | 323 | <50 | <10 |
MCD FEL | + | 60 | R | 492 | <50 | A | 1068 | AC LTNP 8021 | 36 | 694 | 9800 | 11333 |
MCD IBM | + | 27 | R | 327 | <20 | - | <10 | AC LTNP 12001 | 33 | 488 | 7800 | <10 |
MCD REP | + | 41 | R | 305 | ND | R | 837 | AC Prog NAH | 34 | 361 | <20 | <10 |
MCD QOC | + | 62 | R | 445 | <50 | - | <10 | AC LTNP 4035 | ND | 417 | <20 | <10 |
MCD UAG | − | 86 | R | 1789 | - | - | 12770 | AC LTNP 2002 | 42 | 1895 | 830 | <10 |
MCD EUG | − | 66 | R | 789 | - | R | 51 | AC LTNP 11007 | 44 | 709 | 4200 | <10 |
Median | - | 48a | - | 282b | 50c | - | 240d | 41a | 342b | 830c | 10d |
MCD patients (n=12) . | AC, HIV coinfected (n=12) . | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Code . | HIV . | Age . | MCD status . | CD4/mm3 . | HIV VL (cp/mL) . | Associated-KS . | HHV-8 VL (cp/1.5 105 PBMC) . | Code . | Age . | CD4/mm3 . | HIV VL (cp/mL) . | HHV-8 VL (cp/1.5 105 PBMC) . |
MCD MED | + | 39 | A | 260 | ND | - | 365 | AC Prog 210 | 42 | 279 | 70 000 | <10 |
MCD NIV | + | 38 | A | 180 | ND | - | <10 | AC Prog 238 | 48 | 273 | <800 | ND |
MCD IOP | + | 56 | A | 171 | 100 000 | A | ND | AC LTNP 9006 | 38 | 258 | 40 000 | <10 |
MCD RAM | + | ND | A | 92 | ND | A | ND | AC Prog 212 | 41 | 258 | <800 | <10 |
MCD NEG | + | 37 | A | 34 | ND | A | 240 | AC Prog 204 | 40 | 254 | ND | <10 |
MCD LOR | + | ND | A | 260 | ND | A | ND | AC Prog REV | 57 | 323 | <50 | <10 |
MCD FEL | + | 60 | R | 492 | <50 | A | 1068 | AC LTNP 8021 | 36 | 694 | 9800 | 11333 |
MCD IBM | + | 27 | R | 327 | <20 | - | <10 | AC LTNP 12001 | 33 | 488 | 7800 | <10 |
MCD REP | + | 41 | R | 305 | ND | R | 837 | AC Prog NAH | 34 | 361 | <20 | <10 |
MCD QOC | + | 62 | R | 445 | <50 | - | <10 | AC LTNP 4035 | ND | 417 | <20 | <10 |
MCD UAG | − | 86 | R | 1789 | - | - | 12770 | AC LTNP 2002 | 42 | 1895 | 830 | <10 |
MCD EUG | − | 66 | R | 789 | - | R | 51 | AC LTNP 11007 | 44 | 709 | 4200 | <10 |
Median | - | 48a | - | 282b | 50c | - | 240d | 41a | 342b | 830c | 10d |
VL indicates viral load; cp, copies; A, active; R, remission; Prog, progressor for HIV infection; LTNP, long-term nonprogressor for HIV infection; and ND, not determined.
*P = .29, nonparametric Mann-Whitney test.
†P = .35, nonparametric Mann-Whitney test.
‡P = .51, nonparametric Mann-Whitney test.
§P = .02, nonparametric Mann-Whitney test.